• No results found

Cell-cell interactions in the gastrointestinal tumour-microenvironment Hawinkels, L.J.A.C.

N/A
N/A
Protected

Academic year: 2021

Share "Cell-cell interactions in the gastrointestinal tumour-microenvironment Hawinkels, L.J.A.C."

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cell-cell interactions in the gastrointestinal tumour-microenvironment

Hawinkels, L.J.A.C.

Citation

Hawinkels, L. J. A. C. (2009, January 27). Cell-cell interactions in the gastrointestinal tumour- microenvironment. Retrieved from https://hdl.handle.net/1887/13432

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/13432

Note: To cite this publication please use the final published version (if applicable).

(2)

Chapter 2

Outline and aim of the thesis

(3)

Chapter 2

- 46 -

In normal tissue homeostasis as well as in pathological conditions cells are influenced by surrounding cells both via direct cell-cell contact and soluble factors. Interactions of malignant cells with the tumour-microenvironment have been shown to be very important in the progression of carcinomas. However, the tumour-microenvironment is very complex and although animal models provide the complexity of the different cell types in a living animal, they do not necessarily reflect of the human tumour-microenvironment due to interspecies differences in for example growth factors and their receptors. Therefore, when studying cancer cells one should preferentially take their human tumour-microenvironment into account. This thesis evaluates cell-cell interactions by using various in vitro 3-dimensional cell culture models. After analysis of the human tissue by determination of protein expression levels and cellular localisation by immunohistochemistry, in vitro human cell models, closely resembling the in vivo situation, are developed. The aim is to elucidate the interaction between colon cancer cells with two prominent cell types in the tumour-microenvironment:

angiogenic endothelial cells and myofibroblasts.

Chapter 3 describes the expression and cellular localization of TGF-1 in gastric cancer, focusing on the active TGF-1 molecule, as this is presumably the key mediator of myofibroblast differentiation. In chapter 4 these observations are confirmed in a larger series colorectal cancer samples and a new method to quantify the myofibroblast content in these samples is described. These chapters reveal that enhanced active TGF- levels are clinically important and correlate to the presence of myofibroblasts. Subsequent studies described in chapter 5 evaluate the activation mechanism of TGF- and illustrates that the interaction between tumour cells and fibroblasts leads to myofibroblast differentiation and subsequent upregulation of MMPs in both tumour cells and myofibroblasts, reflecting a double paracrine tumour-promoting mechanism.

The contribution of myofibroblast and neutrophil derived MMPs to the initiation of the angiogenic switch by liberation of VEGF from colon cancer extracellular matrix, is described in chapter 6, showing a key role for neutrophil-derived MMP-9 in the initiation of the angiogenic switch. Besides MMP-9 also endothelial MMP-7 contributes the angiogenesis as described in chapter 7. To be able to quantify MMP-7 activity levels, chapter 8 describes the development of a MMP-7 bioactivity assay. Furthermore the contribution of cathepsin S to the angiogenic process, by liberating pro-angiogenic molecules for colon cancer extracellular matrix and a new method for the identification of specific inhibiting peptides using phage display is described in chapter 9. Finally, chapter 10 describes the role of the TGF- co- receptor Endoglin as an additional factor in colorectal cancer angiogenesis. This receptor is

(4)

mainly expressed by angiogenic endothelial cells and has been implicated in the pro- angiogenic effects of TGF-. The role of MMPs in the cleavage of this membrane receptor into soluble Endoglin is also investigated. The different studies in this thesis are summarized and discussed in chapter 11.

(5)

Chapter 2

- 48 -

Referenties

GERELATEERDE DOCUMENTEN

As shown by staining for pan-Cytokeratin (C, epithelial marker), Vimentin (Vim, D, mesenchymal marker) and Smooth Muscle Actin (SMA, E smooth muscle/myofibroblast marker )

SMA levels were determined by ELISA in dismembrator type homogenates from normal colorectal mucosa, adenomas and carcinomas. Immunohistochemistry on Tu1-Tu4 samples, SMA =

Co-culture of fibroblasts with HCT116 medium leads to strongly increased TGF- signalling (A), increased levels active TGF- in the medium after stimulation (B) and

The number of sprouts is significantly induced by VEGF, and is inhibited by Bevacizumab (Bmab). MMP-9 treated HT29 spheroid medium showed, like VEGF, significant induction of

MMP-7 staining was also demonstrated in colonic endothelial cells adjacent to MMP-7 positive malignant epithelial cells, without detectable MMP-7 mRNA levels in endothelial cells

In the urine from the same patients all matrilysin was present in the active form (27-208 ng/ml). A) Standard curves for APMA-activated recombinant human matrilysin using a

Both K1 and K1-C peptides were able to inhibit 125 I-BSA degradation by proteinase-K in a dose-dependent manner (Figure 3C) with IC 50 values of 4 and 91 PM, respectively.

Of several membrane receptors like the VEGF receptor and Endoglin also soluble variants have been described, which seem to be involved in several pathological conditions. Increased